Emmaus Life Sciences, Inc. SEC filings EMMA

Emmaus Life Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 2, 2009. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Emmaus Life Sciences, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Sep 2, 2026 May 30, 2025
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
3 Initial insider ownership Apr 21, 2026 Apr 16, 2026
8-K Current report
Officer or director change
Apr 17, 2026 Apr 16, 2026
8-K Current report
Officer or director change
Apr 14, 2026 Apr 13, 2026
8-K Current report
Results of operations
Mar 31, 2026 Mar 30, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Material agreement
Mar 4, 2026 Mar 2, 2026
8-K Current report
Material agreement, Other events
Dec 31, 2025 Dec 24, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 22, 2025 Dec 17, 2025
8-K Current report
Officer or director change
Dec 19, 2025 Dec 15, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Officer or director change
Jul 1, 2025 Jun 30, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Auditor change
May 6, 2025 May 2, 2025
8-K Current report
Results of operations
Apr 14, 2025 Apr 14, 2025
10-K Annual report Apr 14, 2025 Dec 31, 2024
NT 10-K Notification of late filing Apr 1, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 4, 2025 —
8-K Current report
Results of operations
Nov 19, 2024 Nov 19, 2024
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
NT 10-Q Notification of late filing Nov 14, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Nov 6, 2024 Nov 4, 2024
8-K Current report
Auditor change
Oct 25, 2024 Oct 22, 2024
3 Initial insider ownership Oct 9, 2024 Oct 1, 2024
8-K Current report
Officer or director change
Oct 4, 2024 Sep 30, 2024
4 Insider transaction Sep 18, 2024 Sep 16, 2024
8-K Current report
Results of operations, Auditor change
Sep 10, 2024 Sep 5, 2024
10-Q Quarterly report Sep 10, 2024 Jun 30, 2024
10-Q Quarterly report Sep 10, 2024 Mar 31, 2024
NT 10-Q Filing Aug 15, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Jul 17, 2024 Jul 15, 2024
8-K Current report
Results of operations
Jul 3, 2024 Jul 3, 2024
10-K Annual report Jul 3, 2024 Dec 31, 2023
8-K Current report
Bylaw or fiscal year change
May 28, 2024 May 23, 2024
NT 10-K Notification of late filing Apr 1, 2024 Dec 31, 2023
4 Insider transaction Feb 29, 2024 Feb 26, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
Feb 26, 2024 Feb 21, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4/A Form 4/a submission Jan 3, 2024 Aug 25, 2023
SC 13G Ownership over 5% (passive) Dec 22, 2023 —
4 Insider transaction Dec 21, 2023 Dec 20, 2023
3/A Form 3/a submission Dec 20, 2023 Oct 4, 2022
8-K Current report
Material agreement, Unregistered share sale
Dec 20, 2023 Dec 15, 2023
4 Insider transaction Dec 19, 2023 Oct 9, 2022
4 Insider transaction Dec 19, 2023 Dec 15, 2023
4 Insider transaction Dec 4, 2023 Aug 25, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Officer or director change
Oct 4, 2023 Oct 2, 2023
8-K Current report
Officer or director change
Aug 23, 2023 Aug 18, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
4 Insider transaction Jun 2, 2023 Sep 20, 2022
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
Mar 31, 2023 Mar 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Unregistered share sale
Mar 7, 2023 Jan 18, 2023
SC 13D/A Amended ownership over 5% (active) Feb 21, 2023 —
D Filing Jan 31, 2023 —
4 Insider transaction Jan 20, 2023 Jan 18, 2023
D Filing Jan 20, 2023 —
4/A Form 4/a submission Jan 19, 2023 Jan 12, 2023
8-K Current report
Unregistered share sale, Officer or director change
Jan 19, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
4 Insider transaction Jan 17, 2023 Jan 12, 2023
8-K Current report
Shareholder vote results
Dec 12, 2022 Dec 8, 2022
4 Insider transaction Dec 1, 2022 Nov 3, 2022
8-K Current report
Results of operations
Nov 15, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
SC 13D/A Amended ownership over 5% (active) Nov 9, 2022 —
4 Insider transaction Nov 3, 2022 Oct 31, 2022
4 Insider transaction Oct 31, 2022 Oct 24, 2022
DEF 14A Proxy statement Oct 31, 2022 Dec 8, 2022
4 Insider transaction Oct 24, 2022 Oct 19, 2022
PRE 14A Preliminary proxy statement Oct 21, 2022 Dec 8, 2022
4 Insider transaction Oct 19, 2022 Oct 17, 2022
4 Insider transaction Oct 17, 2022 Oct 13, 2022
4 Insider transaction Oct 13, 2022 Oct 12, 2022
4 Insider transaction Oct 12, 2022 Sep 26, 2022
3 Initial insider ownership Oct 6, 2022 Oct 4, 2022
3 Initial insider ownership Oct 6, 2022 Oct 4, 2022
8-K Current report
Officer or director change
Oct 6, 2022 Oct 4, 2022
8-K Current report
Officer or director change
Sep 30, 2022 Sep 28, 2022
8-K Current report
Material agreement, New debt
Aug 19, 2022 Aug 15, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Aug 10, 2022 Aug 4, 2022
4 Insider transaction Jul 25, 2022 Jul 19, 2022
10-K/A Amended annual report Jul 1, 2022 Dec 31, 2021
D Filing Jun 30, 2022 —
8-K Current report
Officer or director change
Jun 10, 2022 Jun 8, 2022
4 Insider transaction Jun 3, 2022 May 27, 2022
4 Insider transaction Jun 2, 2022 May 20, 2022
4 Insider transaction May 19, 2022 May 9, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
4 Insider transaction Apr 12, 2022 Apr 4, 2022
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
4 Insider transaction Mar 2, 2022 Feb 28, 2022
4 Insider transaction Feb 28, 2022 Feb 22, 2022
4 Insider transaction Feb 28, 2022 Feb 24, 2022
4 Insider transaction Feb 23, 2022 Feb 18, 2022
4 Insider transaction Feb 18, 2022 Feb 16, 2022
SC 13D/A Amended ownership over 5% (active) Feb 17, 2022 —
4 Insider transaction Feb 16, 2022 Feb 14, 2022
4 Insider transaction Feb 11, 2022 Feb 9, 2022
4 Insider transaction Feb 9, 2022 Feb 7, 2022
4 Insider transaction Feb 7, 2022 Feb 3, 2022
3 Initial insider ownership Jan 24, 2022 Jan 6, 2022
8-K Current report
Officer or director change
Jan 10, 2022 Jan 6, 2022
4 Insider transaction Jan 5, 2022 Jan 3, 2022
4 Insider transaction Jan 5, 2022 Dec 3, 2021
4 Insider transaction Jan 3, 2022 Dec 28, 2021
S-8 Employee stock plan registration Dec 30, 2021 —
3 Initial insider ownership Dec 28, 2021 Nov 23, 2021
4 Insider transaction Dec 28, 2021 Dec 22, 2021
4 Insider transaction Dec 22, 2021 Dec 17, 2021
3 Initial insider ownership Dec 20, 2021 Nov 23, 2021
4 Insider transaction Dec 17, 2021 Dec 10, 2021
4 Insider transaction Dec 10, 2021 Dec 6, 2021
4 Insider transaction Dec 6, 2021 Dec 2, 2021
4 Insider transaction Dec 2, 2021 Nov 30, 2021
SC 13D/A Amended ownership over 5% (active) Dec 1, 2021 —
3 Initial insider ownership Nov 30, 2021 Nov 23, 2021
4 Insider transaction Nov 30, 2021 Nov 26, 2021
4 Insider transaction Nov 30, 2021 Nov 26, 2021
8-K Current report
Officer or director change, Shareholder vote results
Nov 29, 2021 Nov 23, 2021
4 Insider transaction Nov 26, 2021 Nov 23, 2021
4 Insider transaction Nov 26, 2021 Nov 23, 2021
4 Insider transaction Nov 23, 2021 Nov 15, 2021
4 Insider transaction Nov 23, 2021 Nov 19, 2021
4 Insider transaction Nov 19, 2021 Nov 15, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
4 Insider transaction Oct 22, 2021 Oct 20, 2021
DEF 14A Proxy statement Oct 12, 2021 Nov 23, 2021
8-K Current report
Material agreement
Oct 12, 2021 Oct 7, 2021
4 Insider transaction Oct 7, 2021 Oct 5, 2021
PRE 14A Preliminary proxy statement Sep 30, 2021 Nov 23, 2021
4 Insider transaction Sep 29, 2021 Sep 27, 2021
4 Insider transaction Sep 27, 2021 Sep 23, 2021
4 Insider transaction Sep 23, 2021 Sep 21, 2021
4 Insider transaction Sep 17, 2021 Sep 15, 2021
4 Insider transaction Sep 17, 2021 Sep 15, 2021
4 Insider transaction Sep 13, 2021 Sep 9, 2021
4 Insider transaction Sep 10, 2021 Sep 8, 2021
4 Insider transaction Sep 8, 2021 Sep 3, 2021
4 Insider transaction Sep 2, 2021 Sep 2, 2021
10-Q Quarterly report Sep 1, 2021 Jun 30, 2021
10-Q Quarterly report Sep 1, 2021 Mar 31, 2021
4 Insider transaction Aug 27, 2021 Aug 25, 2021
4 Insider transaction Aug 26, 2021 Aug 24, 2021
10-Q Quarterly report Aug 26, 2021 Jun 30, 2020
10-Q Quarterly report Aug 26, 2021 Sep 30, 2020
10-Q Quarterly report Aug 26, 2021 Mar 31, 2020
4 Insider transaction Aug 23, 2021 Aug 19, 2021
4 Insider transaction Aug 18, 2021 Aug 16, 2021
4 Insider transaction Aug 13, 2021 Aug 11, 2021
4 Insider transaction Aug 10, 2021 Aug 6, 2021
10-K/A Amended annual report Aug 10, 2021 Dec 31, 2020
8-K Current report
Restatement
Aug 10, 2021 Aug 5, 2021
4 Insider transaction Aug 5, 2021 Aug 3, 2021
4 Insider transaction Aug 2, 2021 Jul 29, 2021
4 Insider transaction Jul 28, 2021 Jul 26, 2021
4 Insider transaction Jul 23, 2021 Jul 21, 2021
SC 13D/A Amended ownership over 5% (active) Jul 22, 2021 —
4 Insider transaction Jul 20, 2021 Jul 16, 2021
4 Insider transaction Jul 15, 2021 Jul 13, 2021
4 Insider transaction Jul 12, 2021 Jul 8, 2021
4 Insider transaction Jul 7, 2021 Jul 2, 2021
4 Insider transaction Jul 1, 2021 Jun 29, 2021
4 Insider transaction Jun 28, 2021 Jun 24, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
4 Insider transaction Jun 17, 2021 Jun 15, 2021
4 Insider transaction Jun 14, 2021 Jun 10, 2021
4 Insider transaction Jun 9, 2021 Jun 7, 2021
4 Insider transaction Jun 3, 2021 Jun 1, 2021
4 Insider transaction May 28, 2021 May 26, 2021
4 Insider transaction May 28, 2021 May 26, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EMMA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Torrance, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
822370
Former names
MYnd Analytics, Inc. (until Jul 12, 2019); CNS RESPONSE, INC. (until Dec 10, 2015); STRATIVATION, INC. (until Mar 1, 2007); SalesTactix, Inc. (until Aug 23, 2005); AGE RESEARCH INC (until Aug 5, 2004)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.